Persistent association of nailfold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in patients with juvenile dermatomyositis

Arthritis and Rheumatism

Volumn 58, Issue 2, 2008, Pages 571-576

  Christen Zaech, Stéphanie ^a   Seshadri, Roopa ^a   Sundberg, Joyce ^a   Paller, Amy S ^a   Pachman, Lauren M ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Children's Medical Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ALLELE; ARTICLE; CAPILLAROSCOPY; CHILD; CONTROLLED STUDY; DERMATOMYOSITIS; DISEASE ACTIVITY; DISEASE COURSE; DISEASE DURATION; FEMALE; GENOTYPE; HUMAN; JUVENILE; MAJOR CLINICAL STUDY; MALE; MUSCLE; MUSCULOSKELETAL DISEASE; NAIL; PATHOPHYSIOLOGY; PATIENT MONITORING; PRIORITY JOURNAL; REGRESSION ANALYSIS; SCORING SYSTEM; SKIN; SKIN MANIFESTATION; TISSUE REGENERATION; VASCULAR DISEASE;

ADOLESCENT; CAPILLARIES; CHILD; CHILD, PRESCHOOL; DERMATOMYOSITIS; DISEASE PROGRESSION; FEMALE; GENOTYPE; HLA-DQ ANTIGENS; HUMANS; INFANT; MALE; NAILS; PREDICTIVE VALUE OF TESTS; REGIONAL BLOOD FLOW; SKIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 39749198188     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.23299     Document Type: Article

References (14)

1. Tezak Z, Hoffman EP, Lutz JL, Fedczyna TO, Stephan D, Bremer EG, et al. Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis: a novel model of pathogenesis. J Immunol 2002;168:4154-63.
2. Pachman LM, Lipton R, Ramsey-Goldman R, Shamiyeh E, Abbott K, Mendez EP, et al. History of infection before the onset of juvenile dermatomyositis: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry. Arthritis Rheum 2005;53:166-72.
3. Pachman LM, Litt DL, Rowley AH, Hayford JR, Caliendo J, Heller S, et al. Lack of detection of enteroviral RNA or bacterial DNA in magnetic resonance imaging-directed muscle biopsies from twenty children with active untreated juvenile dermatomyositis. Arthritis Rheum 1995;38:1513-8.
4. Mamyrova G, O'Hanlon TP, Monroe JB, Carrick DM, Malley JD, Adams S, et al. Immunogenetic risk and protective factors for juvenile dermatomyositis in Caucasians. Arthritis Rheum 2006;54:3979-87.
5. Pachman LM, Liotta-Davis MR, Hong DK, Kinsella TR, Mendez EP, Kinder JM, et al. TNFα-308A allele in juvenile dermatomyositis: association with increased production of tumor necrosis factor α, disease duration, and pathologic calcifications. Arthritis Rheum 2000;43:2368-77.
6. Lutz J, Huwiler KG, Fedczyna T, Lechman TS, Crawford S, Kinsella TR, et al. Increased plasma thrombospondin-1 (TSP-1) levels are associated with the TNFα-308A allele in children with juvenile dermatomyositis. Clin Immunol 2003;103:250-63.
7. Pachman LM, Abbott K, Sinacore JM, Amoruso L, Dyer A, Lipton R, et al. Duration of illness is an important variable for untreated children with juvenile dermatomyositis. J Pediatr 2006;148:247-53.
8. Dolezalova P, Young SP, Bacon PA, Southwood TR. Nailfold capillary microscopy in healthy children and in childhood rheumatic diseases: a prospective single; blind observational study. Ann Rheum Dis 2003;62:444-9.
9. Smith RL, Sundberg J, Shamiyah E, Dyer A, Pachman LM. Skin involvement in juvenile dermatomyositis is associated with loss of end row nailfold capillary loops. J Rheumatol 2004;31:1644-9.
10. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975;292:344-7.
11. Bode RK, Klein-Gitelman MS, Miller ML, Lechman TS, Pachman LM. Disease activity score for children with juvenile dermatomyositis: reliability and validity evidence. Arthritis Rheum 2003;49:7-15.
12. Rouster-Stevens KA, Gursahaney A, Ngai KL, Daru JA, Pachman LM. Pharmacokinetic study of oral prednisolone compared with intravenous methylprednisolone in patients with juvenile dermatomyositis. Arthritis Rheum 2008;59:222-6.
13. Spencer CH, Hanson V, Singsen BH, Bernstein BH, Kornreich HK, King KK. Course of treated juvenile dermatomyositis. J Pediatr 1984;105:399-408.
14. Fisler RE, Liang MG, Fuhlbrigge RC, Yalcindag A, Sundel RP. Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis. J Am Acad Dermatol 2002;47:505-11.